Home › Non-Hodgkin Lymphoma › Utah › Salt Lake City
Pag-aaral pangklinika para sa Non-Hodgkin Lymphoma sa Salt Lake City, UT
Isang pag-aaral para sa Non-Hodgkin Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Salt Lake City. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
Nagre-recruitPhase 1/2
- Intermountain Health, Canyons Region, LDS Hospital, Salt Lake City
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Nagre-recruitPhase 2
- Intermountain Healthcare, Salt Lake City
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Nagre-recruitPhase 1
- Intermountain Healthcare, Salt Lake City
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Nagre-recruitPhase 1/2
- Huntsman Cancer Institute, Salt Lake City
- Intermountain Healthcare, Salt Lake City
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Nagre-recruitPhase 3
- Intermountain Healthcare, Salt Lake City
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
Nagre-recruitPhase 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Nagre-recruitObservasyonal na pag-aaral
- University of Utah, Salt Lake City
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Nagre-recruitPhase 1
- University of Utah, Salt Lake City
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Nagre-recruitPhase 1/2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
Nagre-recruitObservasyonal na pag-aaral
- Huntsman Cancer Institute at the University of Utah, Salt Lake City
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
Nagre-recruitPhase 1/2
- University of Utah, Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Salt Lake City
ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
Nagre-recruitObservasyonal na pag-aaral
- University of Utah Hospital, Salt Lake City
Pag-aaral para sa Non-Hodgkin Lymphoma sa ibang lungsod
- New York City, NY31 pag-aaral
- Houston, TX31 pag-aaral
- Boston, MA26 pag-aaral
- Nashville, TN21 pag-aaral
- Philadelphia, PA20 pag-aaral
- Baldwin Park, CA19 pag-aaral
- Washington, DC18 pag-aaral
- Chicago, IL18 pag-aaral
- Atlanta, GA18 pag-aaral
- Milwaukee, WI18 pag-aaral
- Columbus, OH18 pag-aaral
- Dallas, TX17 pag-aaral
Iba pang pag-aaral sa Salt Lake City
- Non-Small Cell Lung Cancer31 pag-aaral
- Kanser (lahat ng uri)27 pag-aaral
- Kanser sa Suso27 pag-aaral
- Colorectal Cancer22 pag-aaral
- Kanser sa Baga21 pag-aaral
- Melanoma21 pag-aaral
- Multiple Myeloma21 pag-aaral
- Metastatic Cancer20 pag-aaral
- Kanser sa Ovary19 pag-aaral
- Obesity18 pag-aaral
- Acute Myeloid Leukemia17 pag-aaral
- Pagkabigo ng Puso17 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.